Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infectionBezloto
Posted: Thu Jan 18, 2018 9:46 am
International Clostridium Difficile Support Group
http://cdiffdiscuss.org/PHPBB3/